参考文献/References:
[1]American Psychiatric Association.Diagnostic and Statistical Manual of MentalDisorders[M].5thed.Virginia:American Psychiatric Publishing,2013:55-59.
[2]焦云,刘李燕,蔡小凡.利培酮治疗儿童孤独症谱系障碍11例疗效分析[J].海南医学,2013,24(4):565-566.
[3]谢琴,黄卓玮,王朔,等.利培酮口服液治疗儿童孤独症32例的疗效及安全性[J].中国新药杂志,2013,22(8):941-944.
[4]邹小兵,邓红珠.美国精神疾病诊断分类手册第5版“孤独症谱系障碍诊断标准”解读[J].中国实用儿科杂志,2013,28(8):561-563.
[5]肖宇硕,卢金清,蔡佩,等.中西医治疗儿童自闭症的研究概况[J].湖北中医杂志,2014,36(9):80-82.
[6]Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators;Centers for Disease Control and Prevention(CDC).Prevalence of autism spectrum disorder among childrenaged 8 years-autism and development disabilitiesmonitoring network,11 sites,United States,2010[J].MMWR Surveill Summ,2014,63(2):1-21.
[7]Sun X,Allison C,Matthews FE,et al.Prevalence ofautism in mainland China,Hong Kong and Taiwan:asystematic review and meta-analysis[J].Mol Autism,2013,4(1):7.
[8]Rossignol DA,Genuis SJ,Frye RE.Environmental toxicants and autism spectrum disorders:a systematicreview[J].Transl Psychiatry,2014(4):1-23.
[9]Anagnostou E,Drmic I,Buchanan JA,et al.Autismspectrum disorder:advances in evidence-based practice[J].Can Med Assoc J,2014,186(7):509-519.
[10]于晓辉,宋涛,王真.利培酮在伴有睡眠障碍的孤独症儿童中的应用分析[J].中国现代医生,2015,53(27):34-36.
相似文献/References:
[1]鲁从林,王先丹,杨遂平,等.奥氮平治疗老年痴呆伴精神行为障碍的临床疗效观察[J].医学信息,2018,31(01):138.[doi:10.3969/j.issn.1006-1959.2018.01.053]
LU Cong-lin,WANG Xian-dan,YANG Sui-ping,et al.The Clinical Efficacy of Olanzapine in the Treatment of Alzheimer's Disease with Mental
Behavior Disorder[J].Journal of Medical Information,2018,31(17):138.[doi:10.3969/j.issn.1006-1959.2018.01.053]
[2]蔡 枫,姚雪阳.利培酮与奥氮平治疗酒精所致精神和行为障碍的临床研究[J].医学信息,2018,31(03):137.[doi:10.3969/j.issn.1006-1959.2018.03.048]
CAI Feng,YAO Xue-yang.Clinical Study of Risperidone and Olanzapine in the Treatment of Alcohol-induced Mental and Behavioral Disorders[J].Journal of Medical Information,2018,31(17):137.[doi:10.3969/j.issn.1006-1959.2018.03.048]
[3]陈功琦,梁道博.利培酮联合舍曲林治疗精神分裂症阴性症状
疗效和安全性的Meta分析[J].医学信息,2018,31(10):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
CHEN Gong-qi,LIANG Dao-bo.Meta Analysis of Efficacy and Safety of Risperidone Combined with Sertraline in the Treatment of Schizophrenia with Negative Symptoms[J].Journal of Medical Information,2018,31(17):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
[4]廖鸿钊,钟建辉.氯氮平联合阿立哌唑、利培酮治疗难治性精神分裂症的疗效及对患者糖脂代谢水平的影响[J].医学信息,2022,35(09):141.[doi:10.3969/j.issn.1006-1959.2022.09.035]
LIAO Hong-zhao,ZHONG Jian-hui.Clinical Efficacy of Clozapine Combined with Aripiprazole and Risperidone in the Treatment of Treatment Resistant Sehizophrenia and its Effect on Glucose and Lipid Metabolism[J].Journal of Medical Information,2022,35(17):141.[doi:10.3969/j.issn.1006-1959.2022.09.035]
[5]孙来顺.氨磺必利与利培酮对精神分裂症患者内分泌及糖脂代谢的影响[J].医学信息,2022,35(10):137.[doi:10.3969/j.issn.1006-1959.2022.10.033]
SUN Lai-shun.Effects of Amisulpride and Risperidone on Endocrine And Glucose and Lipid Metabolism in Patients with Schizophrenia[J].Journal of Medical Information,2022,35(17):137.[doi:10.3969/j.issn.1006-1959.2022.10.033]
[6]段宝珍,董晓明.婴儿误服利培酮中毒并抢救成功1例报道[J].医学信息,2020,33(23):190.[doi:10.3969/j.issn.1006-1959.2020.23.059]
[7]王 震.利培酮在难治性分裂情感性精神病中的应用[J].医学信息,2023,36(01):144.[doi:10.3969/j.issn.1006-1959.2023.01.030]
WANG Zhen.Application of Risperidone in Refractory Schizoaffective Psychosis[J].Journal of Medical Information,2023,36(17):144.[doi:10.3969/j.issn.1006-1959.2023.01.030]
[8]孙来顺.氨磺必利与利培酮治疗精神分裂症阴性症状的疗效比较[J].医学信息,2022,35(07):121.[doi:10.3969/j.issn.1006-1959.2022.07.030]
SUN Lai-shun.Comparison of Therapeutic Effects of Amisulpride and Risperidone on Negative Symptoms of Schizophrenia[J].Journal of Medical Information,2022,35(17):121.[doi:10.3969/j.issn.1006-1959.2022.07.030]
[9]田会凤.利培酮联合丙戊酸钠治疗精神分裂症攻击行为的效果及安全性[J].医学信息,2023,36(21):134.[doi:10.3969/j.issn.1006-1959.2023.21.031]
TIAN Hui-feng.Effect and Safety of Risperidone Combined with Sodium Valproate in the Treatment of Aggressive Behavior of Schizophrenia[J].Journal of Medical Information,2023,36(17):134.[doi:10.3969/j.issn.1006-1959.2023.21.031]